Development
ImmunoPrecise Antibodies Ltd.
IPA
$0.6724
-$0.0296-4.22%
NASDAQ
| 10/31/2023 | 07/31/2023 | 04/30/2023 | 01/31/2023 | 10/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -15.31% | -16.22% | -28.09% | -23.11% | -26.45% |
| Total Receivables | -2.89% | 15.05% | 33.03% | -25.60% | 13.06% |
| Inventory | 4.99% | 10.70% | 12.06% | 16.63% | -3.83% |
| Prepaid Expenses | -3.55% | -6.32% | -19.02% | 62.79% | -43.04% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -7.18% | -3.49% | -12.48% | -14.94% | -21.29% |
|
|
|||||
| Total Current Assets | -7.18% | -3.49% | -12.48% | -14.94% | -21.29% |
| Net Property, Plant & Equipment | -8.82% | 22.26% | -2.34% | 11.39% | 190.38% |
| Long-term Investments | -4.33% | 0.74% | -10.67% | 9.84% | -2.86% |
| Goodwill | -4.33% | 0.74% | -10.67% | 9.84% | -2.86% |
| Total Other Intangibles | -6.64% | -2.08% | -3.42% | 6.30% | -5.57% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 6.55% | 0.03% | 0.16% | -3.36% | -9.81% |
| Total Assets | -6.50% | 1.46% | -7.17% | 1.86% | -2.71% |
|
|
|||||
| Total Accounts Payable | 9.02% | -2.26% | -32.14% | -14.60% | 145.73% |
| Total Accrued Expenses | 7.98% | 40.35% | 26.71% | 34.80% | -20.79% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -13.28% | -3.74% | -14.99% | 14.29% | 33.03% |
| Total Finance Division Other Current Liabilities | 30.31% | 30.54% | 31.63% | -17.17% | -45.67% |
| Total Other Current Liabilities | 30.31% | 30.54% | 31.63% | -17.17% | -45.67% |
| Total Current Liabilities | 11.14% | 11.80% | -12.48% | -6.90% | 28.23% |
|
|
|||||
| Total Current Liabilities | 11.14% | 11.80% | -12.48% | -6.90% | 28.23% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -6.94% | 47.04% | -2.18% | 14.34% | 1,587.52% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -6.83% | -2.02% | -8.37% | 6.56% | -4.43% |
| Total Liabilities | -1.80% | 17.15% | -7.86% | 3.93% | 44.11% |
|
|
|||||
| Common Stock & APIC | -5.07% | 3.76% | -1.16% | 2.48% | -5.38% |
| Retained Earnings | 2.04% | -8.12% | -5.77% | -9.85% | -6.34% |
| Treasury Stock & Other | 29.53% | -44.67% | 82.96% | 161.74% | 49.35% |
| Total Common Equity | -8.48% | -3.97% | -6.93% | 1.16% | -12.40% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -8.48% | -3.97% | -6.93% | 1.16% | -12.40% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -8.48% | -3.97% | -6.93% | 1.16% | -12.40% |
|
|
|||||